Global (United States, European Union and China) PDE Inhibitors Market Research Report 2019-2025


    Table of Contents

      1 Report Overview

      • 1.1 Study Scope
      • 1.2 Major Manufacturers Covered in This Report
      • 1.3 Market Segment by Type
        • 1.3.1 Global PDE Inhibitors Market Size Growth Rate by Type (2019-2025)
        • 1.3.2 PDE5
        • 1.3.3 PDE4
        • 1.3.4 Viagra
        • 1.3.5 Cialis
        • 1.3.6 Levitra
        • 1.3.7 Others
      • 1.4 Market Segment by Application
        • 1.4.1 Global PDE Inhibitors Market Share by Application (2019-2025)
        • 1.4.2 Genitourinary
        • 1.4.3 Cardiovascular Diseases
        • 1.4.4 Neurological Diseases
        • 1.4.5 Dermatological Disorders
        • 1.4.6 Respiratory Diseases
        • 1.4.7 Other Indications
      • 1.5 Study Objectives
      • 1.6 Years Considered

      2 Global Growth Trends

      • 2.1 Global PDE Inhibitors Market Size
        • 2.1.1 Global PDE Inhibitors Revenue 2014-2025
        • 2.1.2 Global PDE Inhibitors Sales 2014-2025
      • 2.2 PDE Inhibitors Growth Rate by Regions
        • 2.2.1 Global PDE Inhibitors Sales by Regions 2014-2019
        • 2.2.2 Global PDE Inhibitors Revenue by Regions 2014-2019
      • 2.3 Industry Trends
        • 2.3.1 Market Top Trends
        • 2.3.2 Market Drivers

      3 Market Share by Manufacturers

      • 3.1 PDE Inhibitors Sales by Manufacturers
        • 3.1.1 PDE Inhibitors Sales by Manufacturers 2014-2019
        • 3.1.2 PDE Inhibitors Sales Market Share by Manufacturers 2014-2019
      • 3.2 Revenue by Manufacturers
        • 3.2.1 PDE Inhibitors Revenue by Manufacturers (2014-2019)
        • 3.2.2 PDE Inhibitors Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global PDE Inhibitors Market Concentration Ratio (CR5 and HHI)
      • 3.3 PDE Inhibitors Price by Manufacturers
      • 3.4 Key Manufacturers PDE Inhibitors Plants/Factories Distribution and Area Served
      • 3.5 Date of Key Manufacturers Enter into PDE Inhibitors Market
      • 3.6 Key Manufacturers PDE Inhibitors Product Offered
      • 3.7 Mergers & Acquisitions, Expansion Plans

      4 Market Size by Type

      • 4.1 Sales and Revenue for Each Type
        • 4.1.1 PDE5 Sales and Revenue (2014-2019)
        • 4.1.2 PDE4 Sales and Revenue (2014-2019)
        • 4.1.3 Viagra Sales and Revenue (2014-2019)
        • 4.1.4 Cialis Sales and Revenue (2014-2019)
        • 4.1.5 Levitra Sales and Revenue (2014-2019)
        • 4.1.6 Others Sales and Revenue (2014-2019)
      • 4.2 Global PDE Inhibitors Sales Market Share by Type
      • 4.3 Global PDE Inhibitors Revenue Market Share by Type
      • 4.4 PDE Inhibitors Price by Type

      5 Market Size by Application

      • 5.1 Overview
      • 5.2 Global PDE Inhibitors Sales by Application

      6 United States

      • 6.1 United States PDE Inhibitors Breakdown Data by Company
      • 6.2 United States PDE Inhibitors Breakdown Data by Type
      • 6.3 United States PDE Inhibitors Breakdown Data by Application

      7 European Union

      • 7.1 European Union PDE Inhibitors Breakdown Data by Company
      • 7.2 European Union PDE Inhibitors Breakdown Data by Type
      • 7.3 European Union PDE Inhibitors Breakdown Data by Application

      8 China

      • 8.1 China PDE Inhibitors Breakdown Data by Company
      • 8.2 China PDE Inhibitors Breakdown Data by Type
      • 8.3 China PDE Inhibitors Breakdown Data by Application

      9 Rest of World

      • 9.1 Rest of World PDE Inhibitors Breakdown Data by Company
      • 9.2 Rest of World PDE Inhibitors Breakdown Data by Type
      • 9.3 Rest of World PDE Inhibitors Breakdown Data by Application
      • 9.4 Rest of World PDE Inhibitors Breakdown Data by Countries
        • 9.4.1 Rest of World PDE Inhibitors Sales by Countries
        • 9.4.2 Rest of World PDE Inhibitors Revenue by Countries
        • 9.4.3 Japan
        • 9.4.4 Korea
        • 9.4.5 India
        • 9.4.6 Southeast Asia

      10 Company Profiles

      • 10.1 Hanmi Science Holding
        • 10.1.1 Hanmi Science Holding Company Details
        • 10.1.2 Company Description and Business Overview
        • 10.1.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.1.4 PDE Inhibitors Product Introduction
        • 10.1.5 Hanmi Science Holding Recent Development
      • 10.2 Boehringer Ingelheim
        • 10.2.1 Boehringer Ingelheim Company Details
        • 10.2.2 Company Description and Business Overview
        • 10.2.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.2.4 PDE Inhibitors Product Introduction
        • 10.2.5 Boehringer Ingelheim Recent Development
      • 10.3 Takeda Pharmaceuticals
        • 10.3.1 Takeda Pharmaceuticals Company Details
        • 10.3.2 Company Description and Business Overview
        • 10.3.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.3.4 PDE Inhibitors Product Introduction
        • 10.3.5 Takeda Pharmaceuticals Recent Development
      • 10.4 Pfizer
        • 10.4.1 Pfizer Company Details
        • 10.4.2 Company Description and Business Overview
        • 10.4.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.4.4 PDE Inhibitors Product Introduction
        • 10.4.5 Pfizer Recent Development
      • 10.5 Omeros
        • 10.5.1 Omeros Company Details
        • 10.5.2 Company Description and Business Overview
        • 10.5.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.5.4 PDE Inhibitors Product Introduction
        • 10.5.5 Omeros Recent Development
      • 10.6 Anacor Pharmaceuticals
        • 10.6.1 Anacor Pharmaceuticals Company Details
        • 10.6.2 Company Description and Business Overview
        • 10.6.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.6.4 PDE Inhibitors Product Introduction
        • 10.6.5 Anacor Pharmaceuticals Recent Development
      • 10.7 Otsuka
        • 10.7.1 Otsuka Company Details
        • 10.7.2 Company Description and Business Overview
        • 10.7.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.7.4 PDE Inhibitors Product Introduction
        • 10.7.5 Otsuka Recent Development
      • 10.8 Chiesi Farmaceutici
        • 10.8.1 Chiesi Farmaceutici Company Details
        • 10.8.2 Company Description and Business Overview
        • 10.8.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.8.4 PDE Inhibitors Product Introduction
        • 10.8.5 Chiesi Farmaceutici Recent Development
      • 10.9 Verona Pharma
        • 10.9.1 Verona Pharma Company Details
        • 10.9.2 Company Description and Business Overview
        • 10.9.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.9.4 PDE Inhibitors Product Introduction
        • 10.9.5 Verona Pharma Recent Development
      • 10.10 NuSirt Biopharma
        • 10.10.1 NuSirt Biopharma Company Details
        • 10.10.2 Company Description and Business Overview
        • 10.10.3 Sales, Revenue and Market Share of PDE Inhibitors
        • 10.10.4 PDE Inhibitors Product Introduction
        • 10.10.5 NuSirt Biopharma Recent Development

      11 Value Chain and Sales Channels Analysis

      • 11.1 Value Chain Analysis
      • 11.2 Sales Channels Analysis
        • 11.2.1 PDE Inhibitors Sales Channels
        • 11.2.2 PDE Inhibitors Distributors
      • 11.3 PDE Inhibitors Customers

      12 Market Forecast

      • 12.1 Global PDE Inhibitors Sales and Revenue Forecast 2019-2025
      • 12.2 Global PDE Inhibitors Sales Forecast by Type
      • 12.3 Global PDE Inhibitors Sales Forecast by Application
      • 12.4 PDE Inhibitors Forecast by Regions
        • 12.4.1 Global PDE Inhibitors Sales Forecast by Regions 2019-2025
        • 12.4.2 Global PDE Inhibitors Revenue Forecast by Regions 2019-2025
      • 12.5 United States Market Forecast
      • 12.6 European Union Market Forecast
      • 12.7 China Market Forecast
      • 12.8 Rest of World
        • 12.8.1 Japan
        • 12.8.2 Korea
        • 12.8.3 India

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details

        In 2019, the market size of PDE Inhibitors is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
        In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for PDE Inhibitors.

        This report studies the global market size of PDE Inhibitors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
        This study presents the PDE Inhibitors sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
        For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

        In global market, the following companies are covered:
        Hanmi Science Holding
        Boehringer Ingelheim
        Takeda Pharmaceuticals
        Pfizer
        Omeros
        Anacor Pharmaceuticals
        Otsuka
        Chiesi Farmaceutici
        Verona Pharma
        NuSirt Biopharma

        Market Segment by Product Type
        PDE5
        PDE4
        Viagra
        Cialis
        Levitra
        Others

        Market Segment by Application
        Genitourinary
        Cardiovascular Diseases
        Neurological Diseases
        Dermatological Disorders
        Respiratory Diseases
        Other Indications

        Key Regions split in this report: breakdown data for each region.
        United States
        China
        European Union
        Rest of World (Japan, Korea, India and Southeast Asia)

        The study objectives are:
        To analyze and research the PDE Inhibitors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
        To present the key PDE Inhibitors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
        To split the breakdown data by regions, type, companies and applications
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends, drivers, influence factors in global and regions
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

        In this study, the years considered to estimate the market size of PDE Inhibitors are as follows:
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025



        Summary:
        PDE Inhibitors Market Research Report is PDE Inhibitors Market Report. Get PDE Inhibitors market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on PDE Inhibitors . PDE Inhibitors Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED